Q: Hi folks..thoughts on news that Sangoma going to consolidate shares (23 Sept vote) to pursue a U.S. Listing...and are U still comfortable that Sangoma & Star2Star Technologies are good fit?? Pre-lim results seemed good, and I think audited results are due in Sept?...Should U wait to see how consolidation..& Q results appear, before starting/adding to position...Buy,Hold or Sell...Thanks as always, jb Piedmont QC
Q: Good afternoon, I have a 33% equal split of KXS,CJT and BAM, within a TFSA. I had a good run twice with KXS over the past couple of years, and suspect it may be topping out shortly. Would you consider a switch to TOI to be a sound move. This is a growth portfolio.
Thanks for your always sound advice, Steve.
Q: Does the Affirm/Amazon arrangement have any implications for GSY. I wonder if you could explain in a bit more detail the current relationship between GSY and Affirm, and add some colour to what the future might hold for these relationships.
Q: Do you anticipate a divvy raise again this year in Sept. or will the company forgo a divvy raise with the large acquisition to digest? Every year in Sept there is a raise in the divvy even during the pandemic. What is the current payout ratio? Thx
Q: Kinaxsis, {KXS], is partnering with Exelixus to advance supply chain planning for its cancer drug portfolio. Is this a financially positive union for KXS? Great information & help with my investing decisions. Thanks
Dave
Have you been able to peg an entry price for XBC? It bounced off $2.76. Is shipping and delivery the biggest risk to becoming profitable in the next 1-2 years as systems are manufactured in China? If so is it your belief that the next quarter may be severely impacted and we should wait?
Q: Bought these when you first put them into the Growth Portfolio. Was wondering if you still feel that they have potential. What do you think is needed to get them going in a positive direction? What do their financials look like?
Thanks for your invaluable wisdom and knowledge.
John
Q: Hello, I am up 1000% in DSG and have clearly held it for a long time. I believe in holding my winners, while watching portfolio weightings...It was blind luck rather than skill. Question, how is DSG going forward...any other lucky names especially in the tech sector . I am woefully incompetent here.
Q: What is the latest information on the forward P/E for REAL? It would seem with the price drop REAL must be cheap by now. Let's assume REAL is successful with the onboarding of the tier one client, which they are being quite careful about, and growth continues. Isn't there an opportunity here for new buyers of REAL?
I would like your opinion on when GSY might be considered an addition to the Balanced portfolio? Is it a matter of sector weighting that would preclude its inclusion? It seems to be a perfect stock for the folio. Growth and a growing dividend.
Sorry for putting the team on the spot!
It’s horrible having made so many prescient selections that subscribers are reduced to questions like this one. Lol
Q: GUD's Statement of Cash Flows for the 3 months ended June 30, 2021 shows a 'Purchase of intangible assets' of $217 million, but I could not find an explanation for this significant investment in the MD&A. I would appreciate your comments on this item. Thank you. Edward
Q: I am confused about the 'paired' nature of this stock as it relates to BAM.A. This seems to suggest that if you own BAM.A there is no point in buying or owning BAMR as they are essentially the same stock. Why even list it, then? It doesn't matter how well the company does or doesn't do as its' share price will remain equivalent to BAM.A. Or is this a temporary thing?